Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.00 (0.00%)
Bid:
0.00
Ask:
230.00
Spread: 43.60 (23.391%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Trading Update

8 Sep 2021 09:36

RNS Number : 1062L
B&M European Value Retail S.A.
08 September 2021
 

 

 

 

8 September 2021

B&M European Value Retail S.A.

 

H1 FY22 Trading Update

 

 

B&M European Value Retail S.A. ("the Group"), the UK's leading variety goods value retailer, today provides a trading update relating to its performance to date for the half year ending 25 September 2021 ("H1 FY22").

 

Whilst Group revenues year to date have been broadly in line with market expectations, gross margins have been stronger than originally anticipated in the B&M UK fascia business.

 

Performance of General Merchandise and Seasonal categories has been particularly encouraging. Sell-through rates in those categories have been high and accordingly end of season markdowns have been limited.

 

As a consequence, the Group now expects adjusted EBITDA1 (on a pre-IFRS16 basis) for H1 FY22 (covering the 26 week period to 25 September 2021) to be in the range of £275m to £285m. The analysts' consensus estimate2 for H1 FY22 adjusted EBITDA1 is currently approximately £235m.

 

Although the Group is well positioned for the upcoming Golden Quarter, trading patterns and strength of customer demand remain highly uncertain for the balance of FY22.

 

The Group will provide further detail in its FY22 Interim Results on 11 November 2021.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

 

1. The Directors consider adjusted EBITDA figures to be more reflective of the underlying business performance of the Group and believe that this measure provides additional useful information for investors on the Group's performance. Adjusting items are the effects of derivatives, one off refinancing fees, foreign exchange on the translation of intercompany balances and the effects of revaluing or unwinding balances related to the acquisition of subsidiaries.

2. The consensus estimate for adjusted EBITDA in H1 FY22 is based upon the average of 10 analysts who have provided estimates for that period.

 

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5763

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

Jonny Armstrong, Head of Investor Relations

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Sam Cartwright, Maitland

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGIGDCXXGDGBI
Date   Source Headline
16th Jul 20218:00 amRNSDirector/PDMR Shareholding
14th Jul 202111:22 amRNSDirector/PDMR Shareholding
13th Jul 20219:00 amRNSBlock listing Interim Review
8th Jul 20217:00 amRNSTrading Statement
21st Jun 20217:00 amRNSAnnual Financial Report
3rd Jun 20217:00 amRNSBoard Change
3rd Jun 20217:00 amRNSPreliminary Results
15th Mar 202110:16 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSTrading Update
1st Mar 20219:48 amRNSTotal Voting Rights
25th Feb 20219:20 amRNSDirector Declaration
22nd Feb 20215:06 pmRNSDirector/PDMR Securities
10th Feb 20212:16 pmRNSHolding(s) in Company
9th Feb 202110:05 amRNSHolding(s) in Company
27th Jan 20217:00 amRNSHolding(s) in Company
20th Jan 20213:17 pmRNSHolding(s) in Company
20th Jan 202111:02 amRNSHolding(s) in Company
15th Jan 20214:02 pmRNSHolding(s) in Company
14th Jan 202112:52 pmRNSDirector/PDMR Shareholding
13th Jan 20219:24 amRNSBlock listing Interim Review
12th Jan 202110:00 amRNSDirector Declaration
12th Jan 20217:00 amRNSResults of Placing
11th Jan 20215:22 pmRNSProposed Secondary Placing
7th Jan 20217:00 amRNSTrading Statement
29th Dec 20209:25 amRNSDirector/PDMR Securities
29th Dec 20209:18 amRNSDirector/PDMR Securities
4th Dec 20207:00 amRNSResult of EGM
3rd Dec 20204:20 pmRNSTrading Update
17th Nov 202012:39 pmRNSDirector/PDMR Shareholding
16th Nov 202011:12 amRNSDirector/PDMR Shareholding
13th Nov 202012:35 pmRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSHalf-year Report
28th Oct 20207:00 amRNSNotice of EGM
30th Sep 20209:36 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSTrading Update
21st Sep 20209:53 amRNSResult of AGM
1st Sep 20209:40 amRNSTotal Voting Rights
30th Jul 202011:20 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSTrading Statement
20th Jul 20209:00 amRNSPost Stabilisation Notice
14th Jul 20209:50 amRNSDirector/PDMR Shareholding
13th Jul 20209:09 amRNSBlock listing Interim Review
9th Jul 20202:28 pmRNSBoard Changes
7th Jul 20204:05 pmRNSHolding(s) in Company
7th Jul 20209:01 amRNSHolding(s) in Company
2nd Jul 20206:19 pmRNSPricing of Senior Secured Notes Offering
1st Jul 202011:07 amRNSPre Stabilisation Notice
1st Jul 20209:02 amRNSLaunch of Senior Secured Notes Offering
1st Jul 20207:00 amRNSTrading Statement
1st Jul 20207:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.